NovaBay's Non-Antibiotic Anti-Infective Shows Efficacy In Impetigo Trial
Executive Summary
NovaBay is a step closer to commercializing the first non-antibiotic for treating an infection typically treated with antibiotics, now that its topical gel yielded a 90 percent cure rate in a Phase IIa proof-of-concept trial against impetigo